glp-1 news employers Employer FAQs on the Rise of Drugs for Weight Loss and the Workplace Impact Indiana is expanding access to

Optum Rx ongoing steps Optum Rx already offers a suite of strategies to help payers manage GLP-1 costs, including: Competitive pricing aligned with direct-to-consumer programs

Clinical effectiveness of currently used antidepressant drugs, which target monoaminergic systems in the brain mainly by enhancing serotoninergic and noradrenergic neurotransmission, is very often low and insufficient since approximately only one-third of the patients achieve complete remission of depressive symptoms after therapy

This pipeline indicates that the performance ceiling for peptide-based obesity therapeutics has not yet been reached, sustaining investor and commercial expectations well into the 2030s

Centella Asiatica also often shows up in products that try to treat cellulite or striae

The question is who will lead the change